Izafe Group

0.59 SEK

+0.68 %

Less than 1K followers

IZAFE B

First North Stockholm

Medical Equipment & Services

Health Care

Overview

Financials & Estimates

Ownership

Investor consensus

+0.68 %

-10.27 %

+54.69 %

+140.49 %

+177.57 %

+147.50 %

+50.95 %

-81.08 %

-82.89 %

iZafe Group is a Life Science company focused on the development and marketing of digital medical solutions for home medication management. The company offers, among other things, a medication robot, SaaS solutions and a connected dosing bag. The products aim to reduce the risk of medication errors. Customers include individuals, pharmaceutical companies and public and private healthcare providers globally. iZafe Group is headquartered in Stockholm.

Market cap

216.94M SEK

Turnover

410.97K SEK

Revenue

7.95M

EBIT %

-244.4 %

P/E

-

Dividend yield-%

-

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

16.2

2026

Annual report '25

28.4

2026

Interim report Q1'26

1.9

2026

Interim report Q2'26

All

Press releases

ShowingAll content types

Press release10 hours ago

Monthly Newsletter – November: Momentum, Deliveries, and Continued Expansion

Press release11/28/2025, 8:15 AM

Board Member Increases Shareholding in iZafe Group

Press release11/21/2025, 7:30 AM

iZafe Group strengthens its Nordic expansion through strategic partnership and first major deal in Norway

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Press release11/20/2025, 7:30 AM

iZafe Group signs distribution agreement with Skand for the launch of Dosell on the Icelandic market

Press release11/17/2025, 9:00 AM

iZafe Group’s Business Unit Manager, Helena Kolvik, acquires shares in the company

Press release11/6/2025, 7:30 AM

Monthly Update – October: Growth, Integration and International Expansion

Regulatory press release11/3/2025, 7:30 AM

iZafe Group’s quarterly report Q3, July–September 2025

Press release10/29/2025, 12:20 PM

Nomination Committee appointed ahead of the 2026 Annual General Meeting of iZafe Group AB

Press release10/7/2025, 6:30 AM

September Newsletter – Acquisition, Expansion and Growing Potential

Press release10/3/2025, 10:00 AM

iZafe Group Board Members Acquire Shares

Regulatory press release9/30/2025, 7:15 PM

iZafe Group acquires its distributor in the Netherlands – expects ARR targets to be reached earlier than planned

Press release9/8/2025, 7:15 AM

Monthly Update – August: Continued Growth, Strong Interest, and Preparations for a Busy Fall

Regulatory press release8/29/2025, 6:30 AM

iZafe Group Q2 Interim Report, April-June 2025

Press release8/8/2025, 8:05 AM

Monthly Update July – Summer Calm, Stress Test and Continued Momentum

Press release7/9/2025, 7:00 AM

iZafe Group signs agreement with AddSecure Smart Care Oy to launch Dosell in Finland

Press release7/7/2025, 9:00 AM

Monthly Update June – New Share Issue, Shareholder Campaign, and Continued International Growth

Regulatory press release6/27/2025, 1:00 PM

iZafe Group resolves on a directed share issue of approximately SEK 10 million

Press release6/5/2025, 6:30 AM

Monthly Update May – Surpassing 1,000 Units and Growing Strategic Partnerships

Press release6/3/2025, 12:15 PM

Dosell Reaches 1,000 Units in Operation – Celebrates Milestone with Investor Event in Stockholm

Press release5/20/2025, 11:15 AM

iZafe signs Letter of Intent with JDM Innovation with the goal to initiate a strategic partnership in Europe

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.